re: Ann: June Quarter 2009 Activities and Cas... http://www.asx.com.au/asxpdf/20090727/pdf/31jr2bjfn5f9zx.pdf
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%